DianaSunMD

PubMed

• 43 citations
  Potential cost savings from chemotherapy-induced febrile neutropenia with biosimilar filgrastim and expanded access to targeted antineoplastic treatment across the Eur...
  Diana Sun, Tri Murti Andayani, Ahmed E. Altyar, Karen MacDonald, Ivo Abraham> ;Clinical Therapeutics. 2015 Apr 1
• 9 citations
  Predicting blood pressure outcomes using single-item physician-administered measures: a retrospective pooled analysis of observational studies in Belgium
  L Villa, Diana Sun, Kris Denhaerynck, Stefaan Vancayzeele, Heidi Brié, Christine Hermans, Ann Aerts, Michael Levengood, Karen MacDonald, Ivo Abraham> ;The British Journal of General Practice. 2015 Jan 1
• 50 citations
  Cost savings from anemia management with biosimilar epoetin alfa and increased access to targeted antineoplastic treatment: a simulation for the EU G5 countries
  Ivo Abraham, Lucy M. Han, Diana Sun, Karen MacDonald, Matti Aapro> ;Future Oncology. 2014 Aug 22
• Indurated thigh plaque with associated lymphadenopathy.
  Jordan B Slutsky, Kristina Natan, Gary Clarke, Diana Sun> ;Cutis. 2014 Apr 1
• 7 citations
  Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies w...
  Ivo Abraham, Yoleen Van Camp, L Villa, Kris Denhaerynck, Diana Sun, Stefaan Vancayzeele, Heidi Brié, Ann Aerts, Christine Hermans, Karen MacDonald> ;Journal of Clinical Hypertension. 2013 Sep 1
• Adverse dermatologic effects of cardiovascular drug therapy: part III.
  Frishman, W.H., Brosnan, B.D., Grossman, M., Dasgupta, D., Sun, D.K.> ;Cardiol Rev. 2002-11-01
• Adverse dermatologic effects of cardiovascular drug therapy: part II.
  Frishman, W.H., Brosnan, B.D., Grossman, M., Dasgupta, D., Sun, D.K.> ;Cardiol Rev. 2002-09-01
• Join now to see all